Analysis of the proteoglycans synthesized by human bone cells in vitro. 1987

J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
Bone Research Branch, National Institute of Dental Research, Bethesda, Maryland 20892.

Proteoglycans were isolated by ion-exchange chromatography from the extracted cell layer and culture medium of human bone cell cultures following incubation in the presence of [35S]sulfate and [3H]leucine. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), the synthesized proteoglycans consisted of at least five polydisperse species having median apparent Mr = 600,000, 400,000, 270,000, 135,000 and 40,000. When chromatographed further on octyl-Sepharose CL-4B, the proteoglycans of the cell layer resolved into three peaks. The unbound fraction (peak cell layer-I) contained a 40,000 species consisting of a single glycosaminoglycan chain with or without peptide. Peak cell layer-II contained three sulfated species on electrophoresis: a 600,000 species uniformly distributed across the peak, a 135,000 species enriched in the ascending limb (similar to bone PG-I as described previously), and a 270,000 species (similar to bone PG-I) enriched in the descending limb. Peak cell layer-III, eluting at 0.2% Triton X-100, was highly enriched in a 400,000 proteoglycan component. When media proteoglycans were chromatographed on octyl-Sepharose, two labeled peaks were found. Peak medium-I (unbound) contained a species exhibiting electrophoretic mobility similar to that of the 400,000 species present in peak cell layer-III. Peak II of the culture medium (medium-II) was apparently identical to that of peak cell layer-II, containing the 600,000, 270,000 and 135,000 species. No appreciable 40,000 species was observed in the medium. Treatment of the 600,000 species with either chondroitinase ABC or ACII generated a core protein preparation with bands of 390,000 and 340,000 on SDS gels. Neither the intact nor the chondroitinase ABC-treated 600,000 species was immunoprecipitated by a purified, polyclonal antiserum raised against the core protein of the large chondroitin sulfate proteoglycan of human articular cartilage. Treatment of the 270,000 and 135,000 proteoglycans with chondroitinase ABC, but not ACII, generated a core protein preparation with bands of 52,000 and 49,000 on SDS gels, indicating that they were dermatan sulfate-containing species. The 400,000 species contained both heparan sulfate and chondroitin sulfate, in approximately a 3:1 labeling ratio. This species changed in electrophoretic mobility following treatment with chondroitinase ABC, heparatinase, or both enzymes in combination, which suggested that it may be a hybrid proteoglycan (i.e. both types of glycosaminoglycan chain on the same core protein).(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011133 Polysaccharide-Lyases A group of carbon-oxygen lyases. These enzymes catalyze the breakage of a carbon-oxygen bond in polysaccharides leading to an unsaturated product and the elimination of an alcohol. EC 4.2.2. Polysaccharide Lyase,Polysaccharide-Lyase,Lyase, Polysaccharide,Polysaccharide Lyases
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002808 Chondroitin Lyases Enzymes which catalyze the elimination of delta-4,5-D-glucuronate residues from polysaccharides containing 1,4-beta-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages thereby bringing about depolymerization. EC 4.2.2.4 acts on chondroitin sulfate A and C as well as on dermatan sulfate and slowly on hyaluronate. EC 4.2.2.5 acts on chondroitin sulfate A and C. Chondroitin AC Lyase,Chondroitin B Lyase,Chondroitin Eliminase,Chondroitin Sulfate Lyase,Chondroitinase-AC II,Chondroitinase AC II,Eliminase, Chondroitin,Lyase, Chondroitin AC,Lyase, Chondroitin B,Lyase, Chondroitin Sulfate,Lyases, Chondroitin,Sulfate Lyase, Chondroitin
D002852 Chromatography, Ion Exchange Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. Chromatography, Ion-Exchange,Ion-Exchange Chromatography,Chromatographies, Ion Exchange,Chromatographies, Ion-Exchange,Ion Exchange Chromatographies,Ion Exchange Chromatography,Ion-Exchange Chromatographies
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
August 1998, Matrix biology : journal of the International Society for Matrix Biology,
J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
February 1989, Immunology and cell biology,
J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
June 1990, The Journal of biological chemistry,
J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
May 1995, International endodontic journal,
J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
March 1987, Archives of biochemistry and biophysics,
J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
March 1993, Journal of periodontal research,
J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
July 1991, The Biochemical journal,
J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
March 1990, Archives of biochemistry and biophysics,
J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
November 1987, The American journal of medicine,
J N Beresford, and N S Fedarko, and L W Fisher, and R J Midura, and M Yanagishita, and J D Termine, and P G Robey
January 1988, Connective tissue research,
Copied contents to your clipboard!